Supplemental material
OncoImmunology
Volume 2, 2013 - Issue 5
Open access
722
Views
32
CrossRef citations to date
0
Altmetric
Original Research
The immunomodulatory effects of bevacizumab on systemic immunity in patients with metastatic melanoma
Aaron S. Mansfield Department of Oncology; Mayo Clinic; Rochester, MN USA; Department of Internal Medicine; Division of Hematology; Mayo Clinic; Rochester, MN USACorrespondence[email protected]
, Wendy K. Nevala Department of Immunology; Mayo Clinic; Rochester, MN USA
, Elizabeth Ann T. Lieser Mayo Graduate School; Mayo Clinic; Rochester, MN USA
, Alexey A. Leontovich Health Sciences Research; Mayo Clinic; Rochester, MN USA
& Svetomir N Markovic Department of Oncology; Mayo Clinic; Rochester, MN USA; Department of Internal Medicine; Division of Hematology; Mayo Clinic; Rochester, MN USA; Department of Immunology; Mayo Clinic; Rochester, MN USA
Article: e24436
|
Received 14 Feb 2013, Accepted 25 Mar 2013, Published online: 01 May 2013
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.